公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2013 | The Aurora Kinases Inhibitor VE-465 is a Novel Treatment for Glioblastoma Multiforme | Lee P.-Y.; Chen C.-L.; ZHONG-ZHE LIN ; ANN-LII CHENG ; Chen E.I.-T.; Whang-Peng J.; Huang C.-Y.F. | Oncology | 11 | 9 | |
2010 | Clinical Development and Future Direction for the Treatment of Hepatocellular Carcinoma | Whang-Peng J.; ANN-LII CHENG ; CHIUN HSU ; Chen C.-M. | Journal of Experimental and Clinical Medicine | 25 | 0 | |
2012 | Development and Validation of an Instrument for the Measurement of Health-Related Quality of Life Based on View of Traditional Chinese Medicine Perspective | Chang H.-H.; WEI-CHU CHIE ; Chin Y.-H.; Hsu C.-P.; Liu T.-W.; Whang-Peng J. | Journal of Traditional and Complementary Medicine | 1 | 0 | |
2011 | The development of a novel cancer immunotherapeutic platform using tumor-targeting mesenchymal stem cells and a protein vaccine | Wei H.-J.; Wu A.T.; Hsu C.-H.; Lin Y.-P.; WEN-FANG CHENG ; Su C.-H.; Chiu W.-T.; Whang-Peng J.; Douglas F.L.; Deng W.-P. | Molecular Therapy | 23 | 21 | |
2005 | Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family protein | CHIH-HSIN YANG ; Huang C.-J.; Yang C.-S.; Chu Y.-C.; ANN-LII CHENG ; Whang-Peng J.; PAN-CHYR YANG | Cancer Research | 93 | 88 | |
2004 | Generation of Carcinoembryonic Antigen (CEA)-Specific T-Cell Responses in HLA-A*0201 and HLA-A*2402 Late-Stage Colorectal Cancer Patients after Vaccination with Dendritic Cells Loaded with CEA Peptides | Liu K.-J.; Wang C.-C.; Chen L.-T.; ANN-LII CHENG ; Lin D.-T.; Wu Y.-C.; Yu W.-L.; Hung Y.-M.; Yang H.-Y.; Juang S.-H.; Whang-Peng J. | Clinical Cancer Research | 80 | 76 | |
2006 | Identification of α-enolase as an autoantigen in lung cancer: Its overexpression is associated with clinical outcomes | Chang G.-C.; Liu K.-J.; Hsieh C.-L.; Hu T.-S.; Charoenfuprasert S.; Liu H.-K.; KWEN-TAY LUH ; Hsu L.-H.; Wu C.-W.; Ting C.-C.; Chen C.-Y.; Chen K.-C.; Yang T.-Y.; Chou T.-Y.; Wang W.-H.; Whang-Peng J.; Shih N.-Y. | Clinical Cancer Research | 144 | 126 | |
2011 | Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study | Ch'Ang H.-J.; Lin Y.-L.; HSIU-PO WANG ; Chiu Y.-F.; MING-CHU CHANG ; CHIH-HUNG HSU ; YU-WEN TIEN ; Chen J.-S.; Hsieh R.-K.; Lin P.-W.; Shan Y.-S.; ANN-LII CHENG ; Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T. | International Journal of Radiation Oncology Biology Physics | 19 | 17 | |
2005 | Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients | Su W.-P.; Wen C.-C.; Hsiung C.A.; Su I.-J.; ANN-LII CHENG ; Chang M.-C.; Tsao C.-J.; Kao W.-Y.; Uen W.-C.; CHIH-HUNG HSU ; YEN-SHEN LU ; HWEI-FANG TIEN ; Chao T.-Y.; Chen L.-T.; Whang-Peng J.; PEI-JER CHEN | World Journal of Gastroenterology | 18 | 14 | |
2012 | Long-term results of a randomized, observation-controlled, phase III Trial of Adjuvant Interferon alfa-2b in hepatocellular carcinoma after curative resection | Chen L.-T.; Chen M.-F.; Li L.-A.; PO-HUANG LEE ; Jeng L.-B.; Lin D.-Y.; Wu C.-C.; Mok K.-T.; Chen C.-L.; Lee W.-C.; Chau G.-Y.; Chen Y.-S.; Lui W.-Y.; Hsiao C.-F.; Whang-Peng J.; PEI-JER CHEN | Annals of Surgery | 111 | 106 | |
2005 | Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma | Chen L.-T.; Lin J.-T.; Tai J.J.; Chen G.-H.; Yeh H.-Z.; Yang S.-S.; HSIU-PO WANG ; SUNG-HSIN KUO ; Sheu B.-S.; Jan C.-M.; Wang W.-M.; Wang T.-E.; Wu C.-W.; Chen C.-L.; Su I.-J.; Whang-Peng J.; ANN-LII CHENG | Journal of the National Cancer Institute | 173 | 135 | |
2005 | Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma | Chan A.T.C.; Hsu M.-M.; Goh B.C.; Hui E.P.; Liu T.-W.; Millward M.J.; RUEY-LONG HONG ; Whang-Peng J.; Ma B.B.Y.; To K.F.; Mueser M.; Amellal N.; Lin X.; Chang A.Y. | Journal of Clinical Oncology | 261 | 217 | |
2006 | Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma | Shiah H.-S.; Chao Y.; Chen L.-T.; Yao T.-J.; Huang J.-D.; Chang J.-Y.; PEI-JER CHEN ; Chuang T.-R.; Chin Y.-H.; Whang-Peng J.; Liu T.-W. | Cancer Chemotherapy and Pharmacology | 11 | 12 | |
2016 | A phase i clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment John T Kung | Liu K.-J.; Chao T.-Y.; Chang J.-Y.; ANN-LII CHENG ; Ch'Ang H.-J.; Kao W.-Y.; Wu Y.-C.; Yu W.-L.; Chung T.-R.; Whang-Peng J. | Journal of Biomedical Science | 19 | 16 | |
2006 | Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer | Ch'ang H.-J.; Wang C.-C.; ANN-LII CHENG ; CHIUN HSU ; YEN-SHEN LU ; MING-CHU CHANG ; Lin J.-T.; HSIU-PO WANG ; Shiah H.-S.; Liu T.-W.; Chang J.-Y.; Whang-Peng J.; Chen L.-T. | Journal of Gastroenterology and Hepatology (Australia) | 8 | 8 | |
2006 | Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer | Shiah H.-S.; ANN-LII CHENG ; CHIUN HSU ; CHIH-HUNG HSU ; Liu T.-W.; Chang J.-Y.; Jan C.-M.; Chao Y.; Yu W.-L.; Chuang T.-R.; Whang-Peng J.; Chen L.-T. | Journal of Gastroenterology and Hepatology (Australia) | 6 | 5 | |
2011 | A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan | Chen J.-S.; Chao Y.; Hsieh R.-K.; ANN-LII CHENG ; Chen P.-M.; Chiou T.-J.; Chao T.-Y.; KUN-HUEI YEH ; Chen L.-T.; Whang-Peng J. | Cancer Chemotherapy and Pharmacology | 6 | 5 | |
2009 | Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer | Ch'ang H.-J.; Huang C.-L.; HSIU-PO WANG ; Shiah H.-S.; MING-CHU CHANG ; Jan C.-M.; Chen J.-S.; YU-WEN TIEN ; Hwang T.-L.; Lin J.-T.; ANN-LII CHENG ; Whang-Peng J.; Chen L.-T. | Cancer Chemotherapy and Pharmacology | 13 | 13 | |
1996 | Reappraisal of the early diagnostic value of serial analyses of Western Blot patterns for HIV infection in Neonates | Chen M.-Y.; CHIEN-CHING HUNG ; Lin Y.G.; Lin R.-Y.; Twu S.-J.; Ko Y.-C.; HONG-NERNG HO ; CHANG-PING LIN ; Huang S.-F.; Kerrigan M.E.; Whang-Peng J.; Chuang C.-Y.; Chang K.S.S.; Sung J.-L.; Chang H.-J.; Shih Y.-T.; Chang P.-Y. | International Journal of Infectious Diseases | 0 | 0 | |
1999 | The significance of body weight change in non-Hodgkins lymphoma | Chin Y.H.; Liu J.M.; Tai J.J.; Chuang M.S.; Ho Y.L.; Chen Y.M.; Whang-Peng J.; ANN-LII CHENG | Anticancer Research | 4 | 3 |